gimli
3BBLACKBIO stock analysis context

3B BLACKBIO DX. Stock Context for AI Screening

3B BLACKBIO DX LTD. is a small-cap stock in Healthcare. This page summarizes key screening signals for 3B BLACKBIO DX., including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive 3BBLACKBIO stock page
Price
₹1,138.90
1W return
-4.94%
1M return
-5.04%
3M return
n/a
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
38.75
Turnover
₹1.37 cr

Why it can matter in screens

Financials and Ownership

Quarterly income statement

No recent data available.

Annual income statement

No recent data available.

Balance sheet

No recent data available.

Cash flow

No recent data available.

Shareholding Trend

No recent data available.

Industry Peers

SymbolNameMcapPEROE1Y
SUNPHARMASUN PHARMACEUTICAL IND L429,121.06 cr40.824543+15.06%+7.26%
DIVISLABDIVI S LABORATORIES LTD174,585.42 cr68.707369+17.81%+0.71%
TORNTPHARMTORRENT PHARMACEUTICALS L147,849.87 cr68.354079+29.94%+39.35%
APOLLOHOSPAPOLLO HOSPITALS ENTER. L119,204.71 cr64.295958+23.21%+21.70%
CIPLACIPLA LTD111,088.72 cr29.624450+12.91%-6.65%
ZYDUSLIFEZYDUS LIFESCIENCES LTD108,331.15 cr21.874917+20.44%+16.21%
DRREDDYDR. REDDY S LABORATORIES105,181.70 cr24.542479+13.88%+1.20%
LUPINLUPIN LIMITED103,385.66 cr22.341869+29.22%+15.72%

Try these prompts

Related screen ideas

Data snapshot: 2026-06-03. Not investment advice.